The U.S. government has agreed to hand AstraZeneca PLC up to $1.2 billion to secure the supply of a Potential Coronavirus Vaccine that could be ready as early as October. Under the deal, the government will bankroll a 30,000-person vaccine trial in the U.S. starting in the summer, plus the ramp-up of manufacturing capacity to […]